[The cytoplasmic membranes and lipopolysaccharide of Escherichia coli as immunostimulants]. 1988

E Ivanova, and E Slavcheva, and I Gumpert, and D Georgiev, and P Stoianova

UI MeSH Term Description Entries
D007425 Intracellular Membranes Thin structures that encapsulate subcellular structures or ORGANELLES in EUKARYOTIC CELLS. They include a variety of membranes associated with the CELL NUCLEUS; the MITOCHONDRIA; the GOLGI APPARATUS; the ENDOPLASMIC RETICULUM; LYSOSOMES; PLASTIDS; and VACUOLES. Membranes, Intracellular,Intracellular Membrane,Membrane, Intracellular
D007740 L Forms Bacterial variants, unable to form a complete cell wall, which are formed in cultures by various bacteria; granules (L bodies) appear, unite, and grow into amorphous bodies which multiply and give rise to bacterial cells morphologically indistinguishable from the parent strain.
D008050 Lipid A Lipid A is the biologically active component of lipopolysaccharides. It shows strong endotoxic activity and exhibits immunogenic properties.
D008070 Lipopolysaccharides Lipid-containing polysaccharides which are endotoxins and important group-specific antigens. They are often derived from the cell wall of gram-negative bacteria and induce immunoglobulin secretion. The lipopolysaccharide molecule consists of three parts: LIPID A, core polysaccharide, and O-specific chains (O ANTIGENS). When derived from Escherichia coli, lipopolysaccharides serve as polyclonal B-cell mitogens commonly used in laboratory immunology. (From Dorland, 28th ed) Lipopolysaccharide,Lipoglycans
D008297 Male Males
D003593 Cytoplasm The part of a cell that contains the CYTOSOL and small structures excluding the CELL NUCLEUS; MITOCHONDRIA; and large VACUOLES. (Glick, Glossary of Biochemistry and Molecular Biology, 1990) Protoplasm,Cytoplasms,Protoplasms
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli
D000276 Adjuvants, Immunologic Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund's adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. Immunoactivators,Immunoadjuvant,Immunoadjuvants,Immunologic Adjuvant,Immunopotentiator,Immunopotentiators,Immunostimulant,Immunostimulants,Adjuvant, Immunologic,Adjuvants, Immunological,Immunologic Adjuvants,Immunological Adjuvant,Adjuvant, Immunological,Immunological Adjuvants
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013154 Spleen An encapsulated lymphatic organ through which venous blood filters.

Related Publications

E Ivanova, and E Slavcheva, and I Gumpert, and D Georgiev, and P Stoianova
January 1989, Acta microbiologica Bulgarica,
E Ivanova, and E Slavcheva, and I Gumpert, and D Georgiev, and P Stoianova
November 1977, Biochimica et biophysica acta,
E Ivanova, and E Slavcheva, and I Gumpert, and D Georgiev, and P Stoianova
January 1990, Advances in experimental medicine and biology,
E Ivanova, and E Slavcheva, and I Gumpert, and D Georgiev, and P Stoianova
January 1969, Biochimica et biophysica acta,
E Ivanova, and E Slavcheva, and I Gumpert, and D Georgiev, and P Stoianova
May 1975, Biochimica et biophysica acta,
E Ivanova, and E Slavcheva, and I Gumpert, and D Georgiev, and P Stoianova
February 2022, Scientific reports,
E Ivanova, and E Slavcheva, and I Gumpert, and D Georgiev, and P Stoianova
April 1975, Journal of biochemistry,
E Ivanova, and E Slavcheva, and I Gumpert, and D Georgiev, and P Stoianova
July 1976, Biochimica et biophysica acta,
E Ivanova, and E Slavcheva, and I Gumpert, and D Georgiev, and P Stoianova
January 1993, Acta microbiologica Bulgarica,
E Ivanova, and E Slavcheva, and I Gumpert, and D Georgiev, and P Stoianova
April 1979, Tsitologiia,
Copied contents to your clipboard!